Innoviva (INVA) Non-Current Receivables (2010 - 2013)
Innoviva posted quarterly Non-Current Receivables of $140000.0 for Q1 2013, little changed year-on-year from $140000.0 in Q1 2012, and little changed on a QoQ basis from $140000.0 in Q4 2012.
Innoviva (INVA) has 4 years of Non-Current Receivables data on file, last reported at $140000.0 in Q1 2013.
- For the quarter ending Q1 2013, Non-Current Receivables changed 0.0% year-over-year to $140000.0; the trailing twelve-month figure through Mar 2013 stood at $140000.0 (changed 0.0% YoY), and the FY2012 full-year result was $140000.0, down 41.67% from the prior year.
- Non-Current Receivables for Q1 2013 stood at $140000.0, roughly flat from $140000.0 in the prior quarter.
- Across five years, Non-Current Receivables topped out at $400000.0 in Q4 2010 and bottomed at $140000.0 in Q1 2012.
- The 4-year median for Non-Current Receivables is $240000.0 (2011), against an average of $235555.6.
- The widest annual swing landed in 2012, when Non-Current Receivables plunged 58.82%; it then changed 0.0% in 2013.
- A 4-year view of Non-Current Receivables shows it stood at $400000.0 in 2010, then plunged by 40.0% to $240000.0 in 2011, then plunged by 41.67% to $140000.0 in 2012, then changed by 0.0% to $140000.0 in 2013.
- The last three Non-Current Receivables figures came in at $140000.0 (Q1 2013), $140000.0 (Q4 2012), and $140000.0 (Q3 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.49 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 140,000.00 |
| Dec 31, 2012 | 140,000.00 |
| Sep 30, 2012 | 140,000.00 |
| Jun 30, 2012 | 240,000.00 |
| Mar 31, 2012 | 140,000.00 |
| Dec 31, 2011 | 240,000.00 |
| Sep 30, 2011 | 340,000.00 |
| Jun 30, 2011 | 340,000.00 |
| Dec 31, 2010 | 400,000.00 |